TY - JOUR
T1 - High variability of albuminuria in nondiabetic population
T2 - The Takahata Study
AU - Suzuki, Kazuko
AU - Konta, Tsuneo
AU - Takasaki, Satoshi
AU - Ikeda, Ami
AU - Ichikawa, Kazunobu
AU - Sato, Hitoshi
AU - Shibata, Yoko
AU - Watanabe, Tetsu
AU - Kato, Takeo
AU - Kawata, Sumio
AU - Kubota, Isao
PY - 2009/10/1
Y1 - 2009/10/1
N2 - Background: Albuminuria is a risk factor for renal and cardiovascular events and shows a quick change reflecting vascular status. The aim of this study is to examine the frequency and related factors of the short-term change of albuminuria in nondiabetic Japanese population. Methods: The study subjects were 1,378 individuals (mean age 63.9 years) who attended community-based health checkup in 2004 and 2005 in Takahata town. Albuminuria was evaluated by urine albumin creatinine ratio in morning urine and was categorized into four stages (low normal, high normal, and micro- and macroalbuminuria). Results: At baseline, the prevalence of subjects with low normal, high normal, and micro- and macroalbuminuria was 62.3, 17.3, 18.7, and 1.7%, respectively. During 1 year, progression and remission of albuminuria stages were observed in 23.1 and 14.5% of total subjects, respectively. Both progression and remission of albuminuria were frequently detected at every stage, especially in high normal albuminuria (29% in progression and 39% in remission, respectively). On multivariate analysis, the changes of albuminuria were associated with older age, blood pressures, total protein, estimated glomerular filtration rate (GFR), and urine sodium excretion at baseline, start of antidiabetic drugs, changes in body weight (±1 kg), hemoglobin (±1 g/dl), and urine sodium excretion (±50 mEq/day). Conclusion: This study revealed that albuminuria showed high variability associated with age and small changes in modifiable risk factors during 1 year. In the treatment and risk analysis of subjects with albuminuria, the effect of these factors should be considered.
AB - Background: Albuminuria is a risk factor for renal and cardiovascular events and shows a quick change reflecting vascular status. The aim of this study is to examine the frequency and related factors of the short-term change of albuminuria in nondiabetic Japanese population. Methods: The study subjects were 1,378 individuals (mean age 63.9 years) who attended community-based health checkup in 2004 and 2005 in Takahata town. Albuminuria was evaluated by urine albumin creatinine ratio in morning urine and was categorized into four stages (low normal, high normal, and micro- and macroalbuminuria). Results: At baseline, the prevalence of subjects with low normal, high normal, and micro- and macroalbuminuria was 62.3, 17.3, 18.7, and 1.7%, respectively. During 1 year, progression and remission of albuminuria stages were observed in 23.1 and 14.5% of total subjects, respectively. Both progression and remission of albuminuria were frequently detected at every stage, especially in high normal albuminuria (29% in progression and 39% in remission, respectively). On multivariate analysis, the changes of albuminuria were associated with older age, blood pressures, total protein, estimated glomerular filtration rate (GFR), and urine sodium excretion at baseline, start of antidiabetic drugs, changes in body weight (±1 kg), hemoglobin (±1 g/dl), and urine sodium excretion (±50 mEq/day). Conclusion: This study revealed that albuminuria showed high variability associated with age and small changes in modifiable risk factors during 1 year. In the treatment and risk analysis of subjects with albuminuria, the effect of these factors should be considered.
KW - Albuminuria
KW - Body weight
KW - Salt intake
UR - http://www.scopus.com/inward/record.url?scp=70349669501&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=70349669501&partnerID=8YFLogxK
U2 - 10.1007/s10157-009-0177-3
DO - 10.1007/s10157-009-0177-3
M3 - Article
C2 - 19452243
AN - SCOPUS:70349669501
SN - 1342-1751
VL - 13
SP - 452
EP - 459
JO - Clinical and Experimental Nephrology
JF - Clinical and Experimental Nephrology
IS - 5
ER -